OBJECTIVE: The continued development and use of engineered nanomaterials (ENM) has given rise to concerns over the potential for human health effects. Although the understanding of cardiovascular ENM toxicity is improving, one of the most complex and acutely demanding "special" circulations is the enhanced maternal system to support fetal development. The Barker hypothesis proposes that fetal development within a hostile gestational environment may predispose/program future sensitivity. Therefore, the objective of this study was 2-fold: (1) to determine whether maternal ENM exposure alters uterine and/or fetal microvascular function and (2) test the Barker hypothesis at the microvascular level. STUDY DESIGN: Pregnant (gestation day 10) Sprague-Dawley rats were exposed to nano-titanium dioxide aerosols (11.3 ± 0.039 mg/m(3)/hr, 5 hr/d, 8.2 ± 0.85 days) to evaluate the maternal and fetal microvascular consequences of maternal exposure. Microvascular tissue isolation (gestation day 20) and arteriolar reactivity studies (<150 μm passive diameter) of the uterine premyometrial and fetal tail arteries were conducted. RESULTS: ENM exposures led to significant maternal and fetal microvascular dysfunction, which was seen as robustly compromised endothelium-dependent and -independent reactivity to pharmacologic and mechanical stimuli. Isolated maternal uterine arteriolar reactivity was consistent with a metabolically impaired profile and hostile gestational environment that impacted fetal weight. The fetal microvessels that were isolated from exposed dams demonstrated significant impairments to signals of vasodilation specific to mechanistic signaling and shear stress. CONCLUSION: To our knowledge, this is the first report to provide evidence that maternal ENM inhalation is capable of influencing fetal health and that the Barker hypothesis is applicable at the microvascular level.
OBJECTIVE: The continued development and use of engineered nanomaterials (ENM) has given rise to concerns over the potential for human health effects. Although the understanding of cardiovascular ENM toxicity is improving, one of the most complex and acutely demanding "special" circulations is the enhanced maternal system to support fetal development. The Barker hypothesis proposes that fetal development within a hostile gestational environment may predispose/program future sensitivity. Therefore, the objective of this study was 2-fold: (1) to determine whether maternal ENM exposure alters uterine and/or fetal microvascular function and (2) test the Barker hypothesis at the microvascular level. STUDY DESIGN: Pregnant (gestation day 10) Sprague-Dawley rats were exposed to nano-titanium dioxide aerosols (11.3 ± 0.039 mg/m(3)/hr, 5 hr/d, 8.2 ± 0.85 days) to evaluate the maternal and fetal microvascular consequences of maternal exposure. Microvascular tissue isolation (gestation day 20) and arteriolar reactivity studies (<150 μm passive diameter) of the uterine premyometrial and fetal tail arteries were conducted. RESULTS: ENM exposures led to significant maternal and fetal microvascular dysfunction, which was seen as robustly compromised endothelium-dependent and -independent reactivity to pharmacologic and mechanical stimuli. Isolated maternal uterine arteriolar reactivity was consistent with a metabolically impaired profile and hostile gestational environment that impacted fetal weight. The fetal microvessels that were isolated from exposed dams demonstrated significant impairments to signals of vasodilation specific to mechanistic signaling and shear stress. CONCLUSION: To our knowledge, this is the first report to provide evidence that maternal ENM inhalation is capable of influencing fetal health and that the Barker hypothesis is applicable at the microvascular level.
Authors: Travis L Knuckles; Jinghai Yi; David G Frazer; Howard D Leonard; Bean T Chen; Vince Castranova; Timothy R Nurkiewicz Journal: Nanotoxicology Date: 2011-08-10 Impact factor: 5.913
Authors: Karin S Hougaard; Petra Jackson; Keld A Jensen; Jens J Sloth; Katrin Löschner; Erik H Larsen; Renie K Birkedal; Anni Vibenholt; Anne-Mette Z Boisen; Håkan Wallin; Ulla Vogel Journal: Part Fibre Toxicol Date: 2010-06-14 Impact factor: 9.400
Authors: Wieslaw A Jedrychowski; Frederica P Perera; Umberto Maugeri; John Spengler; Elzbieta Mroz; Elzbieta Flak; Laura Stigter; Renata Majewska; Irena Kaim; Agata Sowa; Ryszard Jacek Journal: Cardiovasc Toxicol Date: 2012-09 Impact factor: 3.231
Authors: Paul J A Borm; David Robbins; Stephan Haubold; Thomas Kuhlbusch; Heinz Fissan; Ken Donaldson; Roel Schins; Vicki Stone; Wolfgang Kreyling; Jurgen Lademann; Jean Krutmann; David Warheit; Eva Oberdorster Journal: Part Fibre Toxicol Date: 2006-08-14 Impact factor: 9.400
Authors: Alaeddin B Abukabda; Elizabeth C Bowdridge; Carroll R McBride; Thomas P Batchelor; William T Goldsmith; Krista L Garner; Sherri Friend; Timothy R Nurkiewicz Journal: Toxicol Appl Pharmacol Date: 2019-02-01 Impact factor: 4.219
Authors: Elizabeth C Bowdridge; Alaeddin B Abukabda; Kevin J Engles; Carroll R McBride; Thomas P Batchelor; William T Goldsmith; Krista L Garner; Sherri Friend; Timothy R Nurkiewicz Journal: Toxicol Sci Date: 2019-06-01 Impact factor: 4.849
Authors: Achini K Vidanapathirana; Leslie C Thompson; Erin E Mann; Jillian T Odom; Nathan A Holland; Susan J Sumner; Li Han; Anita H Lewin; Timothy R Fennell; Jared M Brown; Christopher J Wingard Journal: Reprod Toxicol Date: 2014-08-01 Impact factor: 3.143
Authors: A K Vidanapathirana; L C Thompson; J Odom; N A Holland; S J Sumner; T R Fennell; J M Brown; C J Wingard Journal: J Nanomed Nanotechnol Date: 2014-04-20
Authors: Elizabeth B Engler-Chiurazzi; Phoebe A Stapleton; Jessica J Stalnaker; Xuefang Ren; Heng Hu; Timothy R Nurkiewicz; Carroll R McBride; Jinghai Yi; Kevin Engels; James W Simpkins Journal: J Toxicol Environ Health A Date: 2016-04-19
Authors: A K Vidanapathirana; L C Thompson; M Herco; J Odom; S J Sumner; T R Fennell; J M Brown; C J Wingard Journal: Reprod Toxicol Date: 2017-11-21 Impact factor: 3.143